An evidence-based appraisal of the use of hyperbaric oxygen on flaps and grafts

Plastic and Reconstructive Surgery

Volumn 117, Issue 7 SUPPL., 2006, Pages

  Kindwall, Eric P ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE; NICOTINAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; STEROID; SUPEROXIDE DISMUTASE;

CLINICAL TRIAL; EVIDENCE BASED MEDICINE; GRAFT SURVIVAL; HUMAN; HYPERBARIC OXYGEN; META ANALYSIS; NONHUMAN; NOTE; OUTCOME ASSESSMENT; OXYGEN TOXICITY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SPLIT THICKNESS SKIN GRAFT; SYSTEMATIC REVIEW; TISSUE FLAP; TISSUE GRAFT;

EID: 33748251271     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000225457.61320.b0     Document Type: Note

References (4)

1. Thom, S. R. Antagonism of carbon-monoxide mediated lipid peroxidation by hyperbaric oxygen. Toxicol. Appl. Pharmacol. 105: 340, 1990.
2. Raskin, . H.B.O. inhibits lipid peroxidation in vitro in lung homogenate. Aerospace Med. 42: 28, 1971.
3. Thom, S. R., Mendiguren, I., Hardy, K., et al. Inhibition of human neutrophil beta2-integrin-dependent adherence by hyperbaric O2. Am. J. Physiol. 272: C770, 1997.
4. Mathieu, D., , , et al. Red blood cell deformability and hyperbaric oxygenation. In E. Kindwall (Ed.), Proceedings of the Eighth International Congress on Hyperbaric Medicine. Flagstaff, Ariz.: Best Publishing, 1987. Pp. 27-28.